SBC Medical Group Holdings Incorporated Net Income (Loss) Attributable to Noncontrolling Interest
SBC Medical Group Holdings Incorporated (SBC) reported Net Income (Loss) Attributable to Noncontrolling Interest of $469.47 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-08-13
- SBC Medical Group Holdings Incorporated net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was $469.47K.
- SBC Medical Group Holdings Incorporated net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was $20.95K.
- SBC Medical Group Holdings Incorporated net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was $79.60K, a 818.90% increase year-over-year.
- SBC Medical Group Holdings Incorporated net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was $8.69K, a 452.45% increase year-over-year.
- SBC Medical Group Holdings Incorporated net income (loss) attributable to noncontrolling interest for fiscal 2025 was $59.41K, a 21.43% decline from fiscal 2024.
- SBC Medical Group Holdings Incorporated net income (loss) attributable to noncontrolling interest for fiscal 2024 was $75.62K.
- SBC Medical Group Holdings Incorporated net income (loss) attributable to noncontrolling interest for fiscal 2023 was -$809.43K.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $469.47K 10-Q · filed 2026-08-13 | $490.42K 10-Q · filed 2026-08-13 | $570.02K derived: sum of 3 quarters · filed 2026-08-13 | $578.71K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $20.95K 10-Q · filed 2026-05-14 | $100.55K derived: sum of 2 quarters · filed 2026-05-14 | $109.24K derived: sum of 3 quarters · filed 2026-05-14 | $90.86K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $79.60K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $88.29K derived: sum of 2 quarters · filed 2026-03-27 | $69.91K derived: sum of 3 quarters · filed 2026-08-13 | $59.41K 10-K · filed 2026-03-27 |
| 2025-09-30 | $8.69K 10-Q · filed 2025-11-14 | -$9.70K derived: sum of 2 quarters · filed 2026-08-13 | -$20.19K 10-Q · filed 2025-11-14 | -$11.53K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$18.39K 10-Q · filed 2026-08-13 | -$28.88K 10-Q · filed 2026-08-13 | -$20.22K derived: sum of 3 quarters · filed 2026-08-13 | -$18.65K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$10.50K 10-Q · filed 2026-05-14 | -$1.83K derived: sum of 2 quarters · filed 2026-05-14 | -$260.00 derived: sum of 3 quarters · filed 2026-05-14 | $72.66K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $8.66K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $10.24K derived: sum of 2 quarters · filed 2026-03-27 | $83.15K derived: sum of 3 quarters · filed 2026-03-27 | $75.62K 10-K · filed 2026-03-27 |
| 2024-09-30 | $1.57K 10-Q · filed 2025-11-14 | $74.49K derived: sum of 2 quarters · filed 2025-11-14 | $66.95K 10-Q · filed 2025-11-14 | -$45.66K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $72.92K 10-Q · filed 2025-08-13 | $65.38K 10-Q · filed 2025-08-13 | -$47.24K derived: sum of 3 quarters · filed 2025-08-13 | -$345.86K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | -$7.54K 10-Q · filed 2025-05-15 | -$120.15K derived: sum of 2 quarters · filed 2025-05-15 | -$418.78K derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | -$112.62K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$411.24K derived: sum of 2 quarters · filed 2025-03-28 | -$809.43K 10-K · filed 2025-03-28 | |
| 2023-09-30 | -$298.62K 10-Q · filed 2024-11-13 | -$696.81K 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |